Mark Davison

“Mark Davison is CEO of Blue Sphere Health Ltd (“Bluesphere”) a UK healthcare consultancy focusing on traceability, authentication and patient engagement. He has worked in the drug industry for 25 years including time with GlaxoSmithKline, several contract research organisations, two biotechnology companies and two traceability vendors. With Bluesphere, Mark has worked with a number of global drug companies and public sector organisations on serialisation and traceability. Mark is a frequent speaker at industry conferences and is the author of “Pharmaceutical Anti-Counterfeiting” (476pp, Wiley, N.Y., 2011).”